Name of organisation
1) Department/Research group
2) Organisation/affiliationFundació Institut Català de Farmacologia
Short Name in the inventoryFICF
Administrative Contact
Title Mr
Last name Carmona
First name Hector
Address line 1Vall d'Hebron 119-129
Address line 2Antiga Escola Infermeria
Address line 3Servei de Farmacologia Clínica
CityBarcelona
Postcode08035
CountrySpain
Phone number (incl. country code)34934894105
Alternative phone number34934894494
Fax number (incl. country code)34934894109
Scientific Contact
Title Professor
Last name Figueras
First name Albert
Address line 1Vall d'Hebron 119-129
Address line 2Antiga Escola Infermeria
Address line 3Servei de Farmacologia Clínica
CityBarcelona
Postcode08035
CountrySpain
Phone number (incl. country code)34934894338
Alternative phone number34934894105
Fax number (incl. country code)34934894109
Alternative Scientific Contact
Title Dr
Last name Ibañez
First name Luisa
Address line 1Vall d'Hebron 119-129
Address line 2Antiga Escola Infermeria
Address line 3Sevei de Farmacologia Clínica
CityBarcelona
Postcode08039
CountrySpain
Phone number (incl. country code)34934894545
Alternative phone number34934894105
Fax number (incl. country code)34934894109
2. Description
The Fundació Institut Català de Farmacologia is a WHO Collaborating Centre for Research and Training in Pharmacoepidemiology. Since 1983, it develops research in clinical pharmacology and pharmacoepidemiology. It was a founder of the Spanish System of Pharmacovigilancea nd it is the Regional Centre for Catalonia . Research activities are coupled with undergraduate teaching at the Autonomous University of Barcelona Medical School, training of specialists in clinical pharmacology, and continuous education of health professionals on therapeutics. The FICF gives institutional support to the Ethical Research Committee of Hospital Universitari Vall d’Hebron, the Methods Support Unit for Clinical Research of the Institut de Recerca Vall d’Hebron, the Pharmacotherapeutics Committee of the Hospital Vall d’Hebron, the Pharmacotherapeutics Committee of the Institut Català de la Salut, and other institutional boards of the national and regional health authority.
3. Category
University based
Hospital based
Charity or non-profit organisation
Private Foundation
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
Yes
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
Yes
Pharmacist
No
Yes
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
No
Ethics expertise
Yes
Yes
Legal expertise
No
Yes
Regulatory expertise
Yes
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Gastrointestinal tract
Geriatrics
Immunosuppression
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Paediatrics
Pregnancy
Psychiatry
Renal impairment
6. Design of drug safety/risk-benefit studies published in the past 5 years
Case Control Study
Drug Utilisation
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Greater than 15000
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
costume development
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
Yes
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
Agranulocytosis GWA2
Liver disease GWA2
11. Registries established by centre
Drug RegistryAnti-tuberculous drugs
Disease RegistryAgranulocytosis, upper gastro-intestinal bleeding, Acute liver disease, end-stage renal disease
Other Thrombocytopenia
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Networks registered with ENCePP
ENTIS
EUDRAGENE
EuroDURG
Other networks:
Network nameNationalInternationalLink to webpage
EU PE&PV Research Network
No
Yes